Yuji Yamada Ryohei Abe Yutaka Okano Yoshitaka Miyakawa
10.2169/internalmedicine.56.7862
Intern Med
2017;56(9):1085-1088.
atypical hemolytic uremic syndrome eculizumab peritoneal dialysis thrombotic microangiopathy
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28458317/
Antibodies, Monoclonal, Humanized / therapeutic use Atypical Hemolytic Uremic Syndrome / drug therapy Kidney Failure, Chronic / drug therapy Kidney Failure, Chronic / etiology Thrombotic Microangiopathies / diet therapy Thrombotic Microangiopathies / etiology
Antibodies, Monoclonal, Humanized / therapeutic use Atypical Hemolytic Uremic Syndrome / drug therapy Kidney Failure, Chronic / drug therapy Kidney Failure, Chronic / etiology Thrombotic Microangiopathies / diet therapy Thrombotic Microangiopathies / etiology Case Reports Adult Asian People Atypical Hemolytic Uremic Syndrome / diagnosis Humans Male Treatment Outcome Antibodies, Monoclonal, Humanized eculizumab
PMC5478572
28458317
Long-term Eculizumab Treatment Contributes to Recovery from End-stage Renal Disease Caused by Atypical Hemolytic Uremic Syndrome
2017